Literature DB >> 1281840

Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.

L J Crofford1, H Sano, K Karalis, E L Webster, E A Goldmuntz, G P Chrousos, R L Wilder.   

Abstract

Corticotropin-releasing hormone (CRH), the principal regulator of the hypothalamic-pituitary-adrenal axis, is also secreted in peripheral inflammatory sites, where it acts as a local proinflammatory agent. Arthritis-susceptible LEW/N rats have profoundly deficient hypothalamic CRH responses to inflammatory stimuli and other stressors. Arthritis-resistant F344/N rats, on the other hand, have a robust increase in hypothalamic CRH in response to the same stimuli. Contrasting with these hypothalamic CRH responses, we now show that CRH expression is markedly increased in the joints and surrounding tissues of LEW/N rats with streptococcal cell wall- and adjuvant-induced arthritis, whereas it is not increased in similarly treated F344/N rats and is only transiently increased in congenitally athymic nude LEW.rnu/rnu rats. Glucocorticoid treatment suppressed, but did not eliminate, CRH immunoreactivity in the joints of LEW/N rats. CRH mRNA was present in inflamed synovia, as well as in spinal cord, and inflamed synovia also expressed specific CRH-binding sites. We compared CRH expression in inflamed joints with another well-characterized proinflammatory neuropeptide, substance P (SP), and found that SP immunoreactivity paralleled that of CRH. In summary, although LEW/N rats have deficient hypothalamic CRH responses to inflammatory stimuli compared with F344/N rats, they express relatively high levels of CRH at the site of inflammation. Analogous to SP, CRH may be delivered to the inflammatory site by peripheral nerves and/or synthesized at the inflammatory site. These data provide further support for the concept that CRH not only triggers the pituitary-adrenal antiinflammatory cascade, but also functions as an antithetically active local mediator of acute and chronic inflammatory arthritis. These data also illustrate the complex interrelationships of the nervous, endocrine, immune, and inflammatory systems.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281840      PMCID: PMC443415          DOI: 10.1172/JCI116150

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

Review 1.  The immune-hypothalamic-pituitary-adrenal axis.

Authors:  A Bateman; A Singh; T Kral; S Solomon
Journal:  Endocr Rev       Date:  1989-02       Impact factor: 19.871

2.  Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides.

Authors:  E L Webster; E B De Souza
Journal:  Endocrinology       Date:  1988-02       Impact factor: 4.736

3.  Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression.

Authors:  V K Singh
Journal:  J Neuroimmunol       Date:  1989-08       Impact factor: 3.478

4.  A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.

Authors:  E M Sternberg; W S Young; R Bernardini; A E Calogero; G P Chrousos; P W Gold; R L Wilder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  Functional corticotropin releasing factor receptors in the primate peripheral sympathetic nervous system.

Authors:  R Udelsman; J P Harwood; M A Millan; G P Chrousos; D S Goldstein; R Zimlichman; K J Catt; G Aguilera
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

6.  Stimulation of connective tissue cell growth by substance P and substance K.

Authors:  J Nilsson; A M von Euler; C J Dalsgaard
Journal:  Nature       Date:  1985 May 2-8       Impact factor: 49.962

7.  Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents.

Authors:  T J Coderre; A I Basbaum; J D Levine
Journal:  J Neurophysiol       Date:  1989-07       Impact factor: 2.714

8.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.

Authors:  A E Calogero; W T Gallucci; P W Gold; G P Chrousos
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

9.  Thymus-dependent and -independent regulation of Ia antigen expression in situ by cells in the synovium of rats with streptococcal cell wall-induced arthritis. Differences in site and intensity of expression in euthymic, athymic, and cyclosporin A-treated LEW and F344 rats.

Authors:  R L Wilder; J B Allen; C Hansen
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

10.  Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist.

Authors:  F Y Lam; W R Ferrell
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

View more
  35 in total

1.  Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes.

Authors:  Eric M Smith; Mike Gregg; Farhad Hashemi; Liesl Schott; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Lipopolysaccharide upregulates the expression of corticotropin-releasing hormone via MAP kinase pathway in rat peritoneal macrophages.

Authors:  Wuchao Wang; Xiuzhu Zhang; Lie Yang; Dawei Liu; Guodong Liu; Jihong Zhou
Journal:  Mol Cell Biochem       Date:  2011-09-30       Impact factor: 3.396

3.  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia.

Authors:  M Schafer; S A Mousa; Q Zhang; L Carter; C Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

5.  Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes.

Authors:  M E Quevedo; A Slominski; W Pinto; E Wei; J Wortsman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

6.  Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells.

Authors:  L J Muglia; N A Jenkins; D J Gilbert; N G Copeland; J A Majzoub
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 7.  The emerging role of peripheral corticotropin-releasing hormone (CRH).

Authors:  I Ilias; G Mastorakos
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

8.  Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction.

Authors:  N C Vamvakopoulos; G P Chrousos
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes.

Authors:  Christina Chandras; Yassemi Koutmani; Efi Kokkotou; Charalabos Pothoulakis; Katia P Karalis
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

10.  Alpha-melanocyte-stimulating hormone attenuates behavioral effects of corticotropin-releasing factor in isolated guinea pig pups.

Authors:  Patricia A Schiml-Webb; Emily Miller; Terrence Deak; Michael B Hennessy
Journal:  Dev Psychobiol       Date:  2009-07       Impact factor: 3.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.